Additionally, PD-L1 expression was found to be increased in vivo after three doses of CTX140 1q6d on SP1-AC2M2 tumor cells (CD45−) as well as CD45+ leukocytes in comparison to cells from saline control-treated tumors (Supplementary Fig. 7). The gene discussed is PTPRC; the disease is neoplasm.